ETHSX: Eaton Vance Worldwide Health Sci A

Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Find the latest content and information here about the 2019 Charles Schwab Impact Conference.

Advisors

Receive email updates about fund flows, news, upcoming CE accredited webcasts from industry thought leaders and more.

Content focused on helping financial advisors build successful client relationships and grow their business.

Content geared towards helping financial advisors build better client portfolios.

Get insights on the industry trends and investment news from leading fund managers and experts.

ETHSX Eaton Vance Worldwide Health Sci A


Profile

ETHSX - Profile

Vitals

  • YTD Return 2.7%
  • 3 Yr Annualized Return 11.4%
  • 5 Yr Annualized Return 0.1%
  • Net Assets $1.06 B
  • Holdings in Top 10 40.1%

52 WEEK LOW AND HIGH

$12.72
$10.75
$12.72

Expenses

OPERATING RELATED FEES

  • Expense Ratio 1.16%

SALES FEES

  • Front Load 5.75%
  • Deferred Load N/A

BROKERAGE FEES

  • Turnover 32.00%

TRADING FEES

  • Max Redemption Fee N/A

Min Investment

  • Standard (Taxable) $1,000
  • IRA N/A

Fund Classification


Distributions

  • YTD Total Return 2.7%
  • 3 Yr Annualized Total Return 12.4%
  • 5 Yr Annualized Total Return 5.2%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio 0.61%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    Eaton Vance Worldwide Health Sciences Fund Class A
  • Fund Family Name
    Eaton Vance
  • Inception Date
    Jul 26, 1985
  • Shares Outstanding
    60741450
  • Share Class
    A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Samantha Pandolfi

Fund Description

The fund normally invests at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies principally engaged in the discovery, development, production or distribution of products related to scientific advances in health care, including biotechnology, pharmaceuticals, diagnostics, managed health care and medical equipment and supplies. It has a policy of investing at least 25% of its assets in investments in the medical research and health care industry.


Get Updates About ETHSX

Sign up for Advisor Access to receive email updates about ETHSX competitors, news, CE accredited webcasts and more.

Please Enter Your Email
Please Select Your Advisor Type

Categories

Performance

ETHSX - Performance

Return Ranking - Trailing

Period ETHSX Return Category Return Low Category Return High Rank in Category (%)
YTD 2.7% 0.0% 6.1% 20.16%
1 Yr 16.3% 2.6% 41.8% 48.74%
3 Yr 11.4%* -9.2% 28.4% 35.78%
5 Yr 0.1%* -9.8% 14.6% 62.86%
10 Yr 3.1%* -2.8% 18.8% 86.81%

* Annualized

Return Ranking - Calendar

Period ETHSX Return Category Return Low Category Return High Rank in Category (%)
2019 19.3% 5.7% 55.4% 57.98%
2018 0.8% -25.3% 21.5% 10.81%
2017 13.1% -10.8% 43.9% 60.55%
2016 -24.6% -31.6% 6.9% 92.45%
2015 -1.4% -20.4% 13.8% 43.69%

Total Return Ranking - Trailing

Period ETHSX Return Category Return Low Category Return High Rank in Category (%)
YTD 2.7% 0.0% 6.1% 20.16%
1 Yr 16.3% 2.6% 41.8% 47.06%
3 Yr 12.4%* -9.2% 31.6% 37.61%
5 Yr 5.2%* -9.8% 16.7% 45.71%
10 Yr 12.1%* -2.8% 18.8% 50.55%

* Annualized

Total Return Ranking - Calendar

Period ETHSX Return Category Return Low Category Return High Rank in Category (%)
2019 19.3% 5.7% 55.4% 57.98%
2018 0.8% -25.3% 22.2% 18.92%
2017 16.2% -10.8% 45.8% 62.39%
2016 -14.8% -26.4% 8.7% 60.38%
2015 8.6% -16.6% 15.2% 26.21%

NAV & Total Return History


Holdings

ETHSX - Holdings

Concentration Analysis

ETHSX Category Low Category High ETHSX % Rank
Net Assets 1.06 B 3.58 M 48.1 B 57.48%
Number of Holdings 58 18 399 79.84%
Net Assets in Top 10 414 M 71.5 K 17.4 B 55.81%
Weighting of Top 10 40.13% 21.3% 75.3% 50.39%

Top 10 Holdings

  1. Merck & Co Inc 5.60%
  2. Johnson & Johnson 5.15%
  3. Roche Holding AG Dividend Right Cert. 4.90%
  4. UnitedHealth Group Inc 4.76%
  5. Abbott Laboratories 3.72%
  6. Sanofi SA 3.29%
  7. GlaxoSmithKline PLC 3.26%
  8. Bristol-Myers Squibb Company 3.19%
  9. Anthem Inc 3.14%
  10. Medtronic PLC 3.12%

Asset Allocation

Weighting Return Low Return High ETHSX % Rank
Stocks
99.86% 48.12% 103.54% 13.18%
Cash
0.14% 0.00% 51.88% 83.72%
Preferred Stocks
0.00% 0.00% 1.08% 40.31%
Other
0.00% -27.41% 5.17% 56.59%
Convertible Bonds
0.00% 0.00% 1.54% 34.88%
Bonds
0.00% 0.00% 20.60% 35.66%

Stock Sector Breakdown

Weighting Return Low Return High ETHSX % Rank
Healthcare
100.00% 58.44% 100.00% 11.63%
Utilities
0.00% 0.00% 0.00% 27.91%
Technology
0.00% 0.00% 16.36% 48.06%
Real Estate
0.00% 0.00% 5.84% 33.33%
Industrials
0.00% 0.00% 2.40% 34.88%
Financial Services
0.00% 0.00% 6.09% 44.19%
Energy
0.00% 0.00% 0.43% 31.01%
Communication Services
0.00% 0.00% 1.02% 31.78%
Consumer Defense
0.00% 0.00% 36.20% 33.33%
Consumer Cyclical
0.00% 0.00% 10.50% 32.56%
Basic Materials
0.00% 0.00% 2.02% 46.51%

Stock Geographic Breakdown

Weighting Return Low Return High ETHSX % Rank
US
70.04% 48.12% 99.93% 95.35%
Non US
29.82% 0.00% 39.36% 4.65%

Expenses

ETHSX - Expenses

Operational Fees

ETHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.16% 0.10% 9.84% 55.12%
Management Fee 0.72% 0.09% 1.30% 51.94%
12b-1 Fee 0.25% 0.00% 1.00% 24.29%
Administrative Fee 0.15% 0.03% 0.40% 57.45%

Sales Fees

ETHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load 5.75% 2.50% 5.75% 19.23%
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

ETHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

ETHSX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 32.00% 0.00% 341.00% 27.42%

Distributions

ETHSX - Distributions

Dividend Yield Analysis

ETHSX Category Low Category High ETHSX % Rank
Dividend Yield 0.00% 0.00% 5.20% 37.98%

Dividend Distribution Analysis

ETHSX Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Monthly Annually

Net Income Ratio Analysis

ETHSX Category Low Category High ETHSX % Rank
Net Income Ratio 0.61% -2.24% 2.12% 10.24%

Capital Gain Distribution Analysis

ETHSX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

Dividend Payout History

View More +

Fund Manager Analysis

ETHSX - Fund Manager Analysis

Managers

Samantha Pandolfi


Start Date

Tenure

Tenure Rank

Jul 01, 2016

3.5

3.5%

Ms. Pandolfi is a Vice President of EVAIL. Prior to joining EVAIL, Ms. Pandolfi held similar positions at EVMI. Prior to joining EVMI as a Vice President in November 2015, Ms. Pandolfi was a Portfolio Manager and Research Analyst with Goldman Sachs Asset Management over her fifteen year tenure (2000-2015).

Jason Kritzer


Start Date

Tenure

Tenure Rank

Jul 01, 2016

3.5

3.5%

Mr. Kritzer is a Vice President of Eaton Vance. Prior to joining Eaton Vance in 2012, Mr. Kritzer was a director and equity analyst at BlackRock , Inc. covering the healthcare sector since 2006.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.59 22.31 9.83 19.68